QRDAI Specifications for APP (2025)
Print
Modified on: Thu, 11 Dec, 2025 at 10:23 AM
Use the following CMS Specification links to view the QRDAI specifications and requirements:
Id | QM Title | CMS Specification |
001 | Diabetes: Hemoglobin A1C (HbA1c) Poor Control | CMS122v13 |
| 112 | Breast Cancer Screening | CMS125v13 |
134 | Preventive Care and Screening: Screening for Depression and Follow-up Plan | CMS2v14 |
236 | Controlling High Blood Pressure | CMS165v13 |
QRDAI XPath Reference
| Item | XPath |
| Provider NPI | /ClinicalDocument/documentationOf/performer/assignedEntity/id[@extension]
|
| TIN | /ClinicalDocument/documentationOf/performer/assignedEntity/id[@extension]
|
References
HL7 Implementation Guide for CDA Release 2: Quality Reporting Document Architecture,
Category I, Release 1, Standard for Trial Use Release 5.3 (QRDA I STU 5.3), and subsequent
errata update
HL7 Clinical Document Architecture (CDA) Release 2.0 Normative Edition
Value Set Codes Reference
Did you find it helpful?
Yes
No
Send feedback Sorry we couldn't be helpful. Help us improve this article with your feedback.
